On March 3, 2026 Immunocore Holdings plc (Nasdaq: IMCR) ("Immunocore" or the "Company"), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, reported management will participate at the following conferences in March.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
TD Cowen 46th Annual Healthcare Conference
Presentation: Tuesday, March 3, 2026, at 2:30 p.m. EST
Leerink 2026 Global Healthcare Conference
Fireside Chat: Monday, March 9, 2026, at 3:40 p.m. EST
Barclays 28th Annual Global Healthcare Conference
1x1s and small group meetings: Tuesday, March 10, 2026
UBS Biotech Summit Miami, Catalyst for Change
1x1s and small group meetings: Tuesday, March 10, 2026
Jefferies 2026 Biotech on the Beach Summit
1x1s and small group meetings: Wednesday, March 11, 2026
Where relevant, the presentations will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com. Following the event, a replay of the presentations will be made available for a limited time.
(Press release, Immunocore, MAR 3, 2026, View Source [SID1234663228])